Cujo, I didn,t say it was good that Thoratec may not get approval, my reasons were I was just looking at the fact Thoratec didn,t meet their goals and only managed 64% success rate when their goal was 65%, plus patients are dropping off from compilcations, bleeding and the like.........I know Thoratec are the leader, but when VCR are performing better than the Leader, with a 85% success rate, isn,t that a bit of a poor showing????
I think you have taken my post out of context or I haven,t explained myself properly.
Cheers dma
- Forums
- ASX - By Stock
- VCR
- panel advises fda to approve thoratec pump
VCR
ventracor limited
panel advises fda to approve thoratec pump, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online